Colossal’s Artificial Eggshell Could Resurrect Moa by 2030

By VirentaNews Staff — May 20, 2026

Can science bring back a bird that vanished over 600 years ago? Colossal Biosciences, the company known for its high-profile efforts to resurrect extinct species like the woolly mammoth and dire wolf, now claims a pivotal breakthrough: an artificial eggshell capable of supporting the development of a moa, a towering, flightless bird native to New Zealand that could reach up to 12 feet tall and weigh over 400 pounds. The announcement has reignited debate over the scientific and ethical boundaries of de-extinction. While Colossal touts the synthetic shell as a critical step toward avian revival, many experts in developmental biology and paleogenetics argue that mimicking an eggshell is just the beginning of an immensely complex puzzle. What does it actually take to bring back a species lost to human-driven extinction?

What Did Colossal Actually Achieve?

Colossal Biosciences says it has engineered a bio-mimetic eggshell made from a blend of synthetic and organic materials designed to replicate the strength, porosity, and gas-exchange properties of a natural moa egg. Because moa eggs were exceptionally large—measuring up to 24 centimeters in length—standard avian incubation approaches are insufficient. The artificial shell, the company claims, can maintain the right internal environment for embryonic development, including humidity, temperature, and oxygen diffusion, even at such a scale. This innovation, they argue, removes one of the biggest technical roadblocks to de-extincting birds, which, unlike mammals, cannot be gestated in surrogate mothers. Instead, avian embryos must develop in a precise external environment—an egg. However, the company has not yet demonstrated a viable embryo growing within the shell, nor have they published their findings in a peer-reviewed journal.

What Does the Scientific Community Say?

Independent experts urge caution. Dr. Beth Shapiro, a leading paleogeneticist at the University of California, Santa Cruz and author of How to Clone a Mammoth, told Nature that while artificial eggshells are “an interesting engineering challenge,” they represent only a fraction of the hurdles in avian de-extinction. “You need a viable genome, a host species capable of producing egg cells, and a way to edit those cells with ancient DNA—none of which has been convincingly shown,” she said. Similarly, developmental biologist Dr. Mike McGrew of the Roslin Institute, who has worked on avian genetic engineering, noted that even with a perfect shell, “you still have to grow an embryo that can form proper organs, muscles, and a nervous system—something we can’t yet do outside a natural egg environment.” Colossal’s current model relies on editing the genome of a tinamou, a small South American bird and the moa’s closest living relative, but no successful germline transmission has been reported.

Are There Alternative Views on De-Extinction?

Not all skepticism is purely technical. Some conservation biologists argue that de-extinction diverts attention and funding from preserving currently endangered species. “We’re losing species at an alarming rate right now,” said Dr. Stuart Pimm, a conservation ecologist at Duke University, in an interview with BBC News. “Spending millions to resurrect a bird that went extinct due to overhunting and habitat loss feels like a technological spectacle, not a conservation solution.” Others point out that even if a moa-like bird were hatched, its ecological role in modern New Zealand is uncertain. The ecosystems it once shaped are long gone, replaced by invasive species and human development. There’s also the ethical question of animal welfare—would a lone, genetically engineered moa live a healthy, natural life, or be confined to a lab or zoo as a scientific curiosity?

What Are the Real-World Implications?

Despite the challenges, Colossal’s work could have meaningful spin-offs. The artificial eggshell technology might benefit modern avian conservation, particularly for critically endangered birds with fragile eggs, such as the kakapo or the Philippine eagle. The techniques developed for gene editing in bird cells could also advance agricultural science, enabling disease-resistant poultry strains. Moreover, Colossal’s high-visibility projects have drawn significant investment into genetic rescue technologies. Since its founding in 2021, the company has raised over $225 million, channeling private capital into areas traditionally underfunded in academic research. While the moa may remain out of reach for now, the infrastructure being built—genome editing tools, stem cell platforms, and incubation systems—could one day help save species on the brink of extinction, even if it doesn’t resurrect those already gone.

What This Means For You

The idea of seeing a living moa may captivate the imagination, but it’s still far from reality. Colossal’s artificial eggshell is a step forward in bioengineering, but it’s just one piece of a much larger puzzle. For the public, this development highlights both the promise and limitations of cutting-edge biotech. While we’re gaining powerful tools to manipulate life, reviving extinct species involves far more than technical fixes—it requires ecological, ethical, and societal considerations. The real value may lie not in resurrecting the past, but in protecting the present.

Still, the question remains: if we can bring back an extinct species, should we? And if so, which one deserves priority—the moa, the passenger pigeon, or perhaps a recently extinct frog with a unique medicinal skin compound? As the science advances, so must the conversation.

Source: New Scientist